text
"['\n1. 요약재무정보\n당사는 국제회계기준을 채택하여 제정한 한국채택국제회계기준을 최초 도입하였습니다. 당사의 한국채택국제회계기준으로의 전환일은 2010년 1월 1일이며, 한국채택국제회계기준 채택일은 2011년 1월 1일입니다.가. 요약 연결 재무제표 * 삼성제약(주)와 그 종속기업(연결) (단위 : 원) \n구분\n제 65 기\n제 64 기\n제 63 기\n자산\n\u3000\n\u3000\n\u3000\n\u3000유동자산\n79,724,616,717\n60,978,260,818\n47,711,452,766\n\u3000\u3000현금및현금성자산\n3,151,357,753\n2,931,620,456\n5,390,180,360\n\u3000\u3000단기금융자산\n1,200,000,000\n1,200,000,000\n1,200,000,000\n\u3000\u3000매출채권\n16,699,562,155\n15,432,793,585\n15,540,472,145\n\u3000\u3000단기매매금융자산\n3,816,549,555\n4,230,007,815\n4,052,931,600\n\u3000\u3000기타유동금융자산\n25,247,161,400\n18,295,411,408\n1,766,345,400\n\u3000\u3000기타유동채권\n16,688,725,138\n7,968,252,690\n3,548,543,252\n\u3000\u3000기타유동자산\n540,227,493\n338,379,961\n3,052,374,065\n\u3000\u3000재고자산\n9,308,654,877\n10,581,794,903\n13,160,605,944\n\u3000\u3000매각예정 자산\n3,072,378,346\n\u3000\n\u3000\n\u3000비유동자산\n80,922,047,065\n93,215,932,456\n90,573,294,202\n\u3000\u3000유형자산\n73,435,190,787\n75,038,445,453\n72,405,350,501\n\u3000\u3000영업권\n\u3000\n\u3000\n1,437,394,575\n\u3000\u3000영업권 이외의 무형자산\n3,229,294,090\n2,169,659,807\n2,745,093,939\n\u3000\u3000기타비유동채권\n3,232,400,000\n1,775,920,500\n1,196,072,500\n\u3000\u3000기타비유동금융자산\n955,162,188\n491,562,000\n2,083,416,337\n\u3000\u3000투자부동산 및 기타투자자산\n70,000,000\n13,740,344,696\n10,705,966,350\n\u3000자산총계\n160,646,663,782\n154,194,193,274\n138,284,746,968\n부채\n\u3000\n\u3000\n\u3000\n\u3000유동부채\n24,693,164,014\n52,178,175,261\n36,507,883,787\n\u3000\u3000매입채무\n4,692,343,679\n6,211,165,772\n4,284,952,089\n\u3000\u3000유동성사채\n4,200,675,190\n11,422,695,905\n8,217,718,412\n\u3000\u3000단기차입금\n11,152,000,000\n28,080,000,000\n18,700,000,000\n\u3000\u3000유동성장기차입금\n957,960,000\n957,960,000\n958,400,000\n\u3000\u3000기타유동채무\n3,687,596,385\n5,506,353,584\n4,346,813,286\n\u3000\u3000미지급법인세\n2,588,760\n\u3000\n\u3000\n\u3000비유동부채\n4,290,522,616\n8,147,527,040\n19,399,098,268\n\u3000\u3000사채\n\u3000\n1,790,000,000\n12,229,775,225\n\u3000\u3000장기차입금\n2,149,737,670\n3,116,094,590\n4,077,673,590\n\u3000\u3000기타비유동금융부채\n155,290,000\n127,290,000\n127,290,000\n\u3000\u3000퇴직급여채무\n1,525,334,223\n2,456,857,214\n2,365,044,511\n\u3000\u3000비유동충당부채\n\u3000\n657,285,236\n532,006,717\n\u3000\u3000비유동계약부채\n460,160,723\n\u3000\n\u3000\n\u3000\u3000이연법인세부채\n\u3000\n\u3000\n67,308,225\n\u3000부채총계\n28,983,686,630\n60,325,702,301\n55,906,982,055\n자본\n\u3000\n\u3000\n\u3000\n\u3000지배기업의 소유주에게 귀속되는 자본\n131,662,977,152\n93,868,490,973\n82,377,763,900\n\u3000\u3000자본금\n29,117,523,500\n20,713,440,500\n19,856,785,000\n\u3000\u3000\u3000보통주자본금\n29,117,523,500\n20,713,440,500\n19,856,785,000\n\u3000\u3000자본잉여금\n82,305,312,594\n99,154,747,344\n94,370,737,498\n\u3000\u3000기타자본\n-991,206,478\n-991,206,478\n-1,180,605,305\n\u3000\u3000기타포괄손익누계액\n24,610,931,430\n24,646,132,247\n12,765,714,568\n\u3000\u3000이익잉여금(결손금)\n-3,379,583,894\n-49,654,622,640\n-43,434,867,861\n\u3000비지배지분\n\u3000\n\u3000\n1,013\n\u3000자본총계\n131,662,977,152\n93,868,490,973\n82,377,764,913\n자본과부채총계\n160,646,663,782\n154,194,193,274\n138,284,746,968\n\u3000\n2018.01.01~ 2018.12.31\n2017.01.01~ 2017.12.31\n2016.01.01~ 2016.12.31\n매출액\n46,483,649,019\n41,919,468,821\n47,194,462,058\n매출원가\n37,894,299,742\n36,837,629,934\n38,409,890,008\n매출총이익\n8,589,349,277\n5,081,838,887\n8,784,572,050\n판매비와관리비\n13,373,001,309\n11,962,064,996\n15,111,211,743\n영업이익(손실)\n-4,783,652,032\n-6,880,226,109\n-6,326,639,693\n금융수익\n3,353,515,773\n807,274,366\n334,005,621\n기타수익\n2,768,675,717\n406,054,971\n84,709,870\n금융원가\n2,173,261,228\n2,816,771,536\n6,681,061,125\n기타비용\n1,181,430,355\n2,482,262,995\n4,758,752,404\n법인세비용차감전순이익(손실)\n-2,016,152,125\n-10,965,931,303\n-17,347,737,731\n법인세비용\n59,553,699\n-3,691,970,189\n-129,710,387\n계속영업당기순이익(손실)\n-2,075,705,824\n-7,273,961,114\n-17,218,027,344\n중단영업당기순이익(손실)\n\u3000\n-265,925,711\n-4,399,575,960\n당기순이익(손실)\n-2,075,705,824\n-7,539,886,825\n-21,617,603,304\n계속영업기본주당이익(손실) \n-41\n-182\n-526\n중단영업기본주당이익(손실) \n\u3000\n-7\n-134\n※ 제63기, 제64기, 제65기 연결 재무제표는 한국채택국제회계기준 작성기준에 따라 작성되었으며 외부감사인의 감사 및 검토를 마친 재무제표입니다.\n가-1. 연결재무제표의 연결에 포함된 회사\n사업연도\n연결에 포함된 회사명\n전기대비 연결에 추가된 회사명\n전기대비 연결에서 제외된 회사명\n제65기\n삼성제약헬스케어(주)\n-\n-\n나. 요약 재무정보 (별도) * 삼성제약(주) (단위 : 원) \n구분\n제 65 기\n제 64 기\n제 63 기\n자산\n\u3000\n\u3000\n\u3000\n\u3000유동자산\n79,680,789,054\n60,506,448,867\n50,905,932,535\n\u3000\u3000현금및현금성자산\n2,813,649,305\n2,390,879,865\n5,133,481,073\n\u3000\u3000단기금융자산\n1,200,000,000\n1,200,000,000\n1,200,000,000\n\u3000\u3000기타금융자산\n29,063,710,955\n22,525,419,223\n5,819,277,000\n\u3000\u3000매출채권\n15,997,486,101\n15,086,361,990\n14,443,023,378\n\u3000\u3000기타 채권\n18,206,403,847\n9,085,824,714\n9,809,284,645\n\u3000\u3000재고자산\n8,788,084,869\n9,898,075,782\n11,813,417,694\n\u3000\u3000기타유동자산\n539,075,631\n319,887,293\n2,687,448,745\n\u3000\u3000매각예정 자산\n3,072,378,346\n\u3000\n\u3000\n\u3000비유동자산\n81,302,242,263\n93,583,089,375\n78,442,931,482\n\u3000\u3000기타비유동금융자산\n955,162,188\n491,562,000\n1,298,373,937\n\u3000\u3000기타채권\n3,132,400,000\n1,675,920,500\n324,079,500\n\u3000\u3000유형자산\n73,417,379,317\n75,008,623,206\n57,406,160,383\n\u3000\u3000투자부동산 및 기타투자자산\n70,000,000\n13,740,344,696\n13,778,344,696\n\u3000\u3000영업권 이외의 무형자산\n3,227,300,758\n2,166,638,973\n2,710,888,676\n\u3000\u3000종속기업투자\n500,000,000\n500,000,000\n2,925,084,290\n\u3000자산총계\n160,983,031,317\n154,089,538,242\n129,348,864,017\n부채\n\u3000\n\u3000\n\u3000\n\u3000유동부채\n23,701,252,165\n51,459,446,632\n33,011,189,453\n\u3000\u3000매입채무\n3,885,293,953\n5,606,164,579\n3,645,789,660\n\u3000\u3000유동성회사채\n4,200,675,190\n11,422,695,905\n8,217,718,412\n\u3000\u3000기타유동채무\n3,597,323,022\n5,392,626,148\n3,489,281,381\n\u3000\u3000단기차입금\n11,060,000,000\n28,080,000,000\n16,700,000,000\n\u3000\u3000유동성장기차입금\n957,960,000\n957,960,000\n958,400,000\n\u3000비유동부채\n4,219,547,733\n8,094,515,189\n9,212,985,583\n\u3000\u3000장기차입금\n2,149,737,670\n3,116,094,590\n4,077,673,590\n\u3000\u3000사채\n\u3000\n1,790,000,000\n2,240,000,000\n\u3000\u3000퇴직급여채무\n1,454,359,340\n2,403,845,363\n2,236,015,276\n\u3000\u3000기타비유동금융부채\n155,290,000\n127,290,000\n127,290,000\n\u3000\u3000비유동계약부채\n460,160,723\n\u3000\n532,006,717\n\u3000\u3000비유동충당부채\n\u3000\n657,285,236\n\u3000\n\u3000부채총계\n27,920,799,898\n59,553,961,821\n42,224,175,036\n자본\n\u3000\n\u3000\n\u3000\n\u3000자본금\n29,117,523,500\n20,713,440,500\n19,856,785,000\n\u3000자본잉여금\n82,305,320,005\n99,154,754,755\n92,684,983,101\n\u3000기타자본\n-991,206,478\n-991,206,478\n-1,043,810,478\n\u3000기타포괄손익누계액\n24,610,931,430\n24,646,132,247\n12,775,862,814\n\u3000이익잉여금(결손금)\n-1,980,337,038\n-48,987,544,603\n-37,149,131,456\n\u3000자본총계\n133,062,231,419\n94,535,576,421\n87,124,688,981\n자본과부채총계\n160,983,031,317\n154,089,538,242\n129,348,864,017\n\u3000\n2018.01.01~ 2018.12.31\n2017.01.01~ 2017.12.31\n2016.01.01~ 2016.12.31\n매출액\n42,911,269,792\n39,064,939,438\n40,527,279,306\n매출원가\n36,488,290,560\n35,480,467,673\n32,828,752,275\n매출총이익\n6,422,979,232\n3,584,471,765\n7,698,527,031\n판매비와관리비\n10,544,582,822\n10,285,229,675\n13,812,732,929\n영업이익(손실)\n-4,121,603,590\n-6,700,757,910\n-6,114,205,898\n기타수익\n2,760,373,978\n405,914,285\n84,462,495\n기타비용\n1,181,198,087\n7,388,604,523\n4,758,558,215\n금융수익\n3,429,454,268\n872,037,014\n385,177,292\n금융원가\n2,171,009,875\n2,764,194,626\n6,692,914,098\n법인세비용차감전순이익(손실)\n-1,283,983,306\n-15,575,605,760\n-17,096,038,424\n법인세비용\n59,553,699\n-3,691,970,189\n-129,282,041\n당기순이익(손실)\n-1,343,537,005\n-11,883,635,571\n-16,966,756,383\n\u3000기본주당이익(손실) \n-26\n-298\n-519\n\u3000희석주당이익(손실) \n-26\n-298\n-519\n※ 제63기, 제64기, 제65기 재무제표는 한국채택국제회계기준 작성기준에 따라 작성되었으며 외부감사인의 감사 및 검토를 마친 재무제표입니다.\n']"
